Cover Image
市場調查報告書

射頻燒灼術設備的市場:2017年∼2021年

Global Radiofrequency Ablation Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 323250
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
射頻燒灼術設備的市場:2017年∼2021年 Global Radiofrequency Ablation Market 2017-2021
出版日期: 2017年04月12日 內容資訊: 英文 70 Pages
簡介

全球射頻燒灼術設備市場,預計2017∼2021年以8.78%的年複合成長率(CAGR) 成長。

本報告提供全球射頻燒灼術設備市場相關分析,市場概要和結構,市場規模趨勢(今後5年的預測值),各類型、各用途、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查、考察。

第1章 摘要整理

第2章 調查範圍

第3章 市場調查手法

第4章 簡介

第5章 市場形勢

  • 市場概要
  • 波特的五力分析

第6章 各產品的市場區隔

  • 消耗品、配件市場
  • 系統市場
  • 導管市場

第7章 各用途的市場區隔

  • 腫瘤學
  • 心臟血管
  • 疼痛管理
  • 美容術
  • 婦產科學

第8章 各終端用戶的市場區隔

  • 醫院
  • 外科門診診療所(ASC)
  • 開業醫院

第9章 地理區分

  • 南北美洲的射頻消融術設備市場
  • EMEA(歐洲、中東、非洲)地區的射頻消融術設備市場
  • 亞太地區的射頻消融術設備市場

第10章 決策機構

第11章 市場成長因素與課題

第12章 市場趨勢

第13章 業者情勢

  • 競爭模式

第14章 主要供應商分析

  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker
  • 其他卓越供應商

第15章 附錄

  • 簡稱清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR12460

About Radiofrequency Ablation

Radiofrequency ablation devices are used to treat medical conditions such as cancer tumors with the help of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound by using minimally invasive (MI) techniques. This involves the use of high-frequency electromagnetic waves to generate heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, and remove or trim obstructive tissues and dead nerves. The process is carried out by inserting a special needle through the skin onto the tumor. The procedure targets specific tissue/nerve with radiofrequency electrical energy, heating the tumor through an active exposed electrode tip.

Technavio's analysts forecast the global radiofrequency ablation market to grow at a CAGR of 8.78% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global radiofrequency ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of equipment and accessories used in radiofrequency ablation.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Radiofrequency Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker

Other Prominent Vendors

  • Accuray
  • Advanced Cardiac Therapeutics
  • APT Medical
  • Arthrex
  • AtriCure
  • Biosense Webster
  • BIOTRONIK
  • Bovie Medical
  • CardioFocus
  • CONMED
  • DVx
  • Hansen Medical
  • Halyard Health
  • Imricor Medical Systems
  • Japan Lifeline
  • Merit Medical Systems
  • MicroPort Scientific
  • Osypka Medical
  • PLC Medical Systems
  • RF Medical
  • Smith & Nephew
  • Spacelabs Healthcare
  • Spectranetics
  • Theraclion
  • Total Vein Systems

Market driver

  • Increasing incidence of chronic disorders and growing older population
  • For a full, detailed list, view our report

Market challenge

  • Risks and complications associated with radiofrequency ablation
  • For a full, detailed list, view our report

Market trend

  • New product launches coupled with R&D activities
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Market segmentation by product

  • Global radiofrequency ablation consumables and accessories market
  • Global radiofrequency ablation systems market
  • Global radiofrequency ablation catheters market

PART 07: Market segmentation by application

  • Oncology
  • Cardiovascular
  • Pain management
  • Cosmetology
  • Gynecology

PART 08: Market segmentation by end-user

  • Hospitals
  • ASCs
  • Physicians' offices

PART 09: Geographical segmentation

  • Radiofrequency ablation market in Americas
  • Radiofrequency ablation market in EMEA
  • Radiofrequency ablation market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments

PART 12: Market trends

  • New product launches coupled with R&D activities
  • Increasing M&A
  • Emergence of robotic navigation technologies
  • Adoption of radiofrequency ablation in emerging economies

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key vendor analysis

  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global radiofrequency ablation market 2016-2021 ($ millions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Global radiofrequency ablation market by product type 2016-2021 ($ millions)
  • Exhibit 04: Global radiofrequency ablation market by product type 2016-2021
  • Exhibit 05: Global radiofrequency ablation consumables and accessories market 2016-2021 ($ millions)
  • Exhibit 06: Global radiofrequency ablation systems market 2016-2021 ($ millions)
  • Exhibit 07: Common ablation catheters used during radiofrequency ablation procedure
  • Exhibit 08: Benefits of advanced radiofrequency ablation catheters
  • Exhibit 09: Global radiofrequency ablation catheters market 2016-2021 ($ millions)
  • Exhibit 10: Global radiofrequency ablation market by application 2016
  • Exhibit 11: Global radiofrequency ablation market by end-user 2016
  • Exhibit 12: Global radiofrequency ablation market by geography 2016-2021
  • Exhibit 13: Global radiofrequency ablation market by geography 2016: Lifecycle analysis
  • Exhibit 14: Global radiofrequency ablation market analysis by geography 2016
  • Exhibit 15: Global radiofrequency ablation market by geography 2016-2021 ($ millions)
  • Exhibit 16: Global radiofrequency ablation market by geography 2016-2021
  • Exhibit 17: Radiofrequency ablation market in Americas 2016-2021 ($ millions)
  • Exhibit 18: Radiofrequency ablation market in EMEA 2016-2021 ($ millions)
  • Exhibit 19: Radiofrequency ablation market in APAC 2016-2021 ($ millions)
  • Exhibit 20: Cancer types worldwide 2012
  • Exhibit 21: Impact of drivers
  • Exhibit 22: Product recalls in radiofrequency ablation market 2015-2016
  • Exhibit 23: Impact of challenges
  • Exhibit 24: New product launches 2015-2016
  • Exhibit 25: Ongoing clinical trials for radiofrequency ablation
  • Exhibit 26: Key M&A 2016-2017
  • Exhibit 27: Competitive structure of global radiofrequency ablation market
  • Exhibit 28: Competitive parameters in global radiofrequency ablation market
  • Exhibit 29: AngioDynamics: Strength assessment
  • Exhibit 30: AngioDynamics: Strategy assessment
  • Exhibit 31: AngioDynamics: Opportunity assessment
  • Exhibit 32: Boston Scientific: Strength assessment
  • Exhibit 33: Boston Scientific strategy assessment
  • Exhibit 34: Boston Scientific: Opportunity assessment
  • Exhibit 35: Medtronic: Strength assessment
  • Exhibit 36: Medtronic; Strategy assessment
  • Exhibit 37: Medtronic; Opportunity assessment
  • Exhibit 38: St. Jude Medical: Strength assessment
  • Exhibit 39: St. Jude Medical: Strategy assessment
  • Exhibit 40: St. Jude Medical: Opportunity assessment
  • Exhibit 41: Stryker: Strength assessment
  • Exhibit 42: Stryker: Strategy assessment
  • Exhibit 43: Stryker: Opportunity assessment
Back to Top